{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:25:41Z","timestamp":1793157941249,"version":"4.5.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Continuous SARS-CoV-2 Omicron emergence poses challenges to immune protection from the previous infection\/vaccination in the population. While neutralizing antibodies serve as a key immune protection indicator, their cross-protective effect against novel variants remains limited. However, T cell immunity may confer more durable and broad-spectrum protection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated immune dynamics in four Chinese cohorts comprising BF.7\/BA.5.2, XBB, and JN.1 convalescents, plus tetravalent recombinant protein vaccine recipients. Neutralizing antibodies were assessed against nine variants spanning the emerging evolutionary spectrum. T cell responses were characterized using variant-specific peptide pools. Antigenic relationships were analyzed through multidimensional scaling-based cartography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>BF.7\/BA.5.2 convalescents exhibited progressive antibody evasion, with fold-changes against heterologous variants increasing from 4\u201312-fold initially to &amp;gt; 20-fold at 6 months. XBB convalescents maintained stable short-term responses, while JN.1 convalescents showed superior cross-reactivity against descendant lineages. BA.3.2 demonstrated maximal immune evasion across all groups, occupying the most distant antigenic position. In contrast, T cell immunity exhibited remarkable stability and cross-reactivity, maintaining elevated levels at 6 months with balanced responses against all tested variants. The tetravalent vaccine induced broad-spectrum T cell responses comparable to natural infection, and elicited cross-neutralizing antibody responses against different Omicron variants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Our study reveals SARS-CoV-2 variant-specific antibody escape compensated by stable cross-reactive T cell responses. In the context of continued viral evolution, stimulating robust T cell immune responses may be critical to achieve a high population immune barrier against future coronaviruses\/variants. These findings emphasize the necessity of comprehensive immune evaluation integrating both humoral and cellular components and provide scientific foundations for optimizing vaccine strategies and immune surveillance systems to address emerging viruses and their variants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1731340","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:43:14Z","timestamp":1769755394000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Broad and robust T cell immunity compensates the population immune barrier against antibody-escaping Omicron variants"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuanyuan","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmin","family":"Tian","sequence":"additional","affiliation":[{"name":"Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeerzati","family":"Tuluhongtayi","sequence":"additional","affiliation":[{"name":"Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Song","sequence":"additional","affiliation":[{"name":"Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F.","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, Cheeloo College of Medicine, Shandong University","place":["Jinan, China"]},{"name":"Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory","place":["Guangzhou, China"]},{"name":"Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS)","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Laboratory of Pathogen Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences (CAS)","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Strategic Pandemic Preparedness Action and Research Center (SPARC), Guangzhou National Laboratory","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e70000","DOI":"10.1111\/imr.70000","article-title":"A structural voyage toward the landscape of humoral and cellular immune escapes of SARS - CoV -2","volume":"330","author":"Liu","year":"2025","journal-title":"Immunol Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00744-2","article-title":"Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure","volume":"24","author":"Yang","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00051-8","article-title":"Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant","volume":"23","author":"Uriu","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001070","article-title":"The emergence and implications of SARS-CoV-2 omicron subvariant BA.2.86 on global health","volume":"110","author":"Satapathy","year":"2024","journal-title":"Int J Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1038\/s41467-024-46490-7","article-title":"Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineages combining increased fitness and antibody evasion","volume":"15","author":"Planas","year":"2024","journal-title":"Nat Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2024.101520","article-title":"Genetic variability of the recombinant SARS-CoV-2 XEC: Is it a new evolutionary dead-end lineage","volume":"62","author":"Branda","year":"2024","journal-title":"New Microbes New Infections"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00015-5","article-title":"Virological and antigenic characteristics of SARS-CoV-2 variants LF.7.2.1, NP.1, and LP.8.1","volume":"25","author":"Liu","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00738-2","article-title":"Enhanced immune evasion of SARS-CoV-2 variants KP.3.1.1 and XEC through N-terminal domain mutations","volume":"25","author":"Liu","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00658-9","article-title":"Epidemiological and virological update on the emerging SARS-CoV-2 variant BA.3.2","volume":"26","author":"Zhang","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bsheal.2024.07.005","article-title":"Biosafety and immunology: An interdisciplinary field for health priority","volume":"6","author":"Liu","year":"2024","journal-title":"Biosafety Health"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.708523","article-title":"Declining levels of neutralizing antibodies against SARS-CoV-2 in convalescent COVID-19 patients one year post symptom onset","volume":"12","author":"Xiang","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa659","article-title":"Longitudinal serological analysis and neutralizing antibody levels in coronavirus disease 2019 convalescent patients","volume":"223","author":"Muecksch","year":"2021","journal-title":"J Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.786554","article-title":"Response and duration of serum anti-SARS-CoV-2 antibodies after inactivated vaccination within 160 days","volume":"12","author":"Xu","year":"2021","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100440","article-title":"Heterologous BBIBP-CorV\/ZF2001 vaccination augments neutralization against SARS-CoV-2 variants: A preliminary observation","volume":"21","author":"Zhao","year":"2022","journal-title":"Lancet Regional Health \u2013 Western Pacific"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlife.2024.09.002","article-title":"Comparison of antigen-specific B cell responses reveals disparity in immunogenicity and memory B cell formation across COVID-19 vaccine platforms","volume":"2","author":"Guo","year":"2024","journal-title":"hLife"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bsheal.2024.04.001","article-title":"Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines","volume":"6","author":"Liu","year":"2024","journal-title":"Biosafety Health"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2214314","article-title":"Substantial neutralization escape by SARS-CoV-2 Omicron variants BQ.1.1 and XBB.1","volume":"388","author":"Miller","year":"2023","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2216233","article-title":"Neutralization of BQ.1, BQ.1.1, and XBB with RBD-dimer vaccines","volume":"388","author":"Li","year":"2023","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2119426","article-title":"Effects of a prolonged booster interval on neutralization of Omicron variant","volume":"386","author":"Zhao","year":"2022","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e675","DOI":"10.1002\/mco2.675","article-title":"The rising SARS-CoV-2 JN.1 variant: evolution, infectivity, immune escape, and response strategies","volume":"5","author":"Lu","year":"2024","journal-title":"MedComm"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08315-x","article-title":"Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1","volume":"637","author":"Jian","year":"2025","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101721-061120","article-title":"T cell responses to SARS-coV-2","volume":"41","author":"Sette","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-017-9241-3","article-title":"Human T-cell immunity against the emerging and re-emerging viruses","volume":"60","author":"Zhao","year":"2017","journal-title":"Sci China Life Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01408-18","article-title":"Heterosubtypic protections against human-infecting avian influenza viruses correlate to biased Cross-T-Cell responses","volume":"9","author":"Zhao","year":"2018","journal-title":"mBio"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1107803","article-title":"Defending against SARS-CoV-2: The T cell perspective","volume":"14","author":"Almendro-V\u00e1zquez","year":"2023","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106402","article-title":"Initial antigen encounter determines robust T-cell immunity against SARS-CoV-2 BA.2.86 variant three years later","volume":"90","author":"Rubio","year":"2025","journal-title":"J Infection"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.abh1823","article-title":"Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination","volume":"374","author":"Loyal","year":"2021","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12030564","article-title":"The influence of cross-reactive T cells in COVID-19","volume":"12","author":"Eggenhuizen","year":"2024","journal-title":"Biomedicines"},{"key":"B32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41392-024-01876-3","article-title":"Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents","volume":"9","author":"Wang","year":"2024","journal-title":"Sig\u00a0Transduct Target Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00377-3","article-title":"Profiling the SARS-cov-2-specific T-cell response","volume":"24","author":"Geers","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1086\/656315","article-title":"The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes","volume":"202","author":"Liu","year":"2010","journal-title":"J Infect Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01464-10","article-title":"Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein","volume":"84","author":"Liu","year":"2010","journal-title":"J Virol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab884","article-title":"One-year sustained cellular and humoral immunities in coronavirus disease 2019 (COVID-19) convalescents","volume":"75","author":"Zhang","year":"2022","journal-title":"Clin Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(22)00036-2","article-title":"SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study","volume":"3","author":"Guo","year":"2022","journal-title":"Lancet Microbe"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00460-4","article-title":"Cross-reactive memory T cells and herd immunity to SARS-CoV-2","volume":"20","author":"Lipsitch","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bsheal.2024.06.001","article-title":"An online survey among convalescents 5 months post SARS-CoV-2 infection in China","volume":"6","author":"Wang","year":"2024","journal-title":"Biosafety Health"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2024.101225","article-title":"Global spread of COVID-19\u2019s JN.1 variant: Implications and public health responses","volume":"57","author":"Satapathy","year":"2024","journal-title":"New\u00a0Microbes New Infections"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlife.2024.03.006","article-title":"Modeling viral evolution: A novel SIRSVIDE framework with application to SARS-CoV-2 dynamics","volume":"2","author":"Jin","year":"2024","journal-title":"hLife"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-022-2207-7","article-title":"A spike-trimer protein-based tetravalent COVID-19 vaccine elicits enhanced breadth of neutralization against SARS-CoV-2 Omicron subvariants and other variants","volume":"66","author":"Wang","year":"2023","journal-title":"Sci China Life Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105634","article-title":"SARS-CoV-2 serotyping based on spike antigenicity and its implications for host immune evasion","volume":"114","author":"Ruan","year":"2025","journal-title":"eBioMedicine"},{"key":"B45","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1038\/s41467-022-32665-7","article-title":"Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bsheal.2024.09.002","article-title":"Construction of pseudotyped human coronaviruses and detection of pre-existing antibodies in the human population","volume":"6","author":"Jiang","year":"2024","journal-title":"Biosafety Health"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3201\/eid2701.203515","article-title":"Waning antibody responses in asymptomatic and symptomatic SARS-CoV-2 infection","volume":"27","author":"Choe","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/v16040649","article-title":"Characterizing infections in two epidemic waves of SARS-CoV-2 Omicron variants: A cohort study in Guangzhou, China","volume":"16","author":"Qu","year":"2024","journal-title":"Viruses"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03131-2","article-title":"SARS-CoV-2 correlates of protection from infection against variants of concern","volume":"30","author":"Sun","year":"2024","journal-title":"Nat Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-02051-0","article-title":"T cell immune evasion by\u00a0SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots","volume":"26","author":"Tian","year":"2025","journal-title":"Nat\u00a0Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115543","article-title":"Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC","volume":"44","author":"Wang","year":"2025","journal-title":"Cell Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00308-1","article-title":"Antigenic and virological characteristics of SARS-CoV-2 variants BA.3.2, XFG, and NB.1.8.1","volume":"25","author":"Guo","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"101165","DOI":"10.1016\/j.lanmic.2025.101165","article-title":"Host cell entry and neutralisation sensitivity of SARS-CoV-2 BA.3.2","volume":"6","author":"Zhang","year":"2025","journal-title":"Lancet Microbe"},{"key":"B55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.hlife.2023.07.002","article-title":"Distinctive serotypes of SARS-related coronaviruses defined by convalescent sera from unvaccinated individuals","volume":"1","author":"Tan","year":"2023","journal-title":"hLife"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.hlife.2023.12.007","article-title":"Is the time right for systematically serotyping SARS-related coronaviruses","volume":"2","author":"Tan","year":"2024","journal-title":"hLife"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-024-00062-z","article-title":"Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins","volume":"43","author":"Li","year":"2024","journal-title":"EMBO J"},{"key":"B58","article-title":"On the doctrine of original antigenic sin","volume":"104","author":"Francis","year":"1960","journal-title":"Proc Am Philos Soc"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2021.09.001","article-title":"Immune imprinting and SARS-CoV-2 vaccine design","volume":"42","author":"Wheatley","year":"2021","journal-title":"Trends Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abo2202","article-title":"Divergent SARS-CoV-2 Omicron\u2013reactive T and B cell responses in COVID-19 vaccine recipients","volume":"7","author":"GeurtsvanKessel","year":"2022","journal-title":"Sci Immunol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"eabj1750","DOI":"10.1126\/sciimmunol.abj1750","article-title":"SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients","volume":"6","author":"Geers","year":"2021","journal-title":"Sci Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-022-00838-5","article-title":"T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant","volume":"19","author":"Choi","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-024-01903-7","article-title":"Vaccine-induced T cell responses control Orthoflavivirus challenge infection without neutralizing antibodies in humans","volume":"10","author":"Kalimuddin","year":"2025","journal-title":"Nat Microbiol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlife.2024.01.005","article-title":"Safety, immunogenicity, and preliminary efficacy of a randomized clinical trial of omicron XBB.1.5-containing bivalent mRNA vaccine","volume":"2","author":"Yu","year":"2024","journal-title":"hLife"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf6840","article-title":"Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice","volume":"371","author":"Cohen","year":"2021","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.cell.2022.04.029","article-title":"Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2","volume":"185","author":"Xu","year":"2022","journal-title":"Cell"},{"key":"B69","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.chom.2023.11.012","article-title":"Enhanced neutralization of SARS-CoV-2 variant BA.2.86 and XBB sub-lineages by a tetravalent COVID-19 vaccine booster","volume":"32","author":"Wang","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlife.2024.03.001","article-title":"Safety and immunogenicity of COVID-19 vaccine ZF2001 in Chinese aged 60 years and older","volume":"2","author":"Gao","year":"2024","journal-title":"hLife"},{"key":"B71","doi-asserted-by":"publisher","first-page":"eadh0687","DOI":"10.1126\/sciimmunol.adh0687","article-title":"SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19","volume":"8","author":"Cai","year":"2023","journal-title":"Sci Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlife.2024.05.004","article-title":"Nasal mucosal secretory immunoglobulin A but not serum antibodies is resistant to Omicron evasion","volume":"2","author":"Chen","year":"2024","journal-title":"hLife"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.05.010","article-title":"SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19","volume":"29","author":"Grifoni","year":"2021","journal-title":"Cell Host Microbe"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1731340\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:43:16Z","timestamp":1769755396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1731340\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":73,"alternative-id":["10.3389\/fimmu.2026.1731340"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1731340","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"article-number":"1731340"}}